Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study
Authors:
- 4 August 2022
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 26 (11) , 1119-1129
Abstract
Background High serum alkaline phosphatase (ALP) levels are associated with excess all-cause and cardiovascular mortality in patients undergoing hemodialysis (HD). However, the long-term relationship between serum ALP levels and infection-related mortality remains unclear. Methods A total of 3502 maintenance HD patients were registered in the Q-Cohort Study, an observational cohort study in Japan. The primary outcome was infection-related mortality during a 10-year follow-up period. The covariate of interest was serum ALP levels at baseline. The association between serum ALP levels and infection-related mortality was calculated using a Cox proportional hazards model and a Fine–Gray subdistribution hazards model with non-infection-related death as a competing risk. Results During the follow-up period, 446 patients died of infection. According to their baseline serum ALP levels, the patients were categorized into sex-specific quartiles (Q1–Q4). Compared with patients in the lowest serum ALP quartile (Q1), those in the highest quartile (Q4) had a significantly higher multivariable-adjusted hazard ratio (HR) of 1.70 [95% confidence interval (CI) 1.24–2.32] for infection-related mortality. Furthermore, the HR for every 50 U/L increase in serum ALP levels was 1.24 (95% CI 1.12–1.36) for infection-related mortality. These associations remained consistent in the competing risk model: subdistribution HR, 1.47; 95% CI 1.07–2.03 for Q4 compared with Q1. Conclusion Higher serum ALP levels were significantly associated with a higher risk of infection-related mortality in patients undergoing HD.Keywords
Funding Information
- Kidney Foundation, Japan (H19 JKFB 07-13, H20 JKFB 08–8, H23 JKFB 11-11)
This publication has 43 references indexed in Scilit:
- Risks of Subsequent Hospitalization and Death in Patients with Kidney DiseaseClinical Journal of the American Society of Nephrology, 2012
- Decreases in PTH in Japanese Hemodialysis Patients with Secondary HyperparathyroidismClinical Journal of the American Society of Nephrology, 2011
- Bone Alkaline Phosphatase and Mortality in Dialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Serum alkaline phosphatase and mortality in hemodialysis patientsClinical Nephrology, 2010
- Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxificationProceedings of the National Academy of Sciences, 2010
- Association of Serum Alkaline Phosphatase with Coronary Artery Calcification in Maintenance Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Serum Alkaline Phosphatase Predicts Mortality among Maintenance Hemodialysis PatientsJournal of the American Society of Nephrology, 2008
- Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcificationKidney International, 2008
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Partial residuals for the proportional hazards regression modelBiometrika, 1982